AFME — Affluent Medical SAS Income Statement
0.000.00%
Last trade - 00:00
- €48.82m
- €42.27m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | — |
Cost of Revenue | |||||
Gross Profit | — | -3.11 | -2.52 | -2.44 | — |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 15 | 13 | 13.2 | 14.3 | 15.4 |
Operating Profit | -15 | -13 | -13.2 | -14.3 | -15.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -16.8 | -14.5 | -15.3 | -15.4 | -15.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.6 | -14.3 | -14.8 | -15.2 | -15.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -16.6 | -14.3 | -14.8 | -15.2 | -15.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -16.6 | -14.3 | -14.8 | -15.2 | -15.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.756 | -0.646 | -0.656 | -0.62 | -0.38 |
Dividends per Share |